EcoR1 Capital

EcoR1 Capital as of Sept. 30, 2016

Portfolio Holdings for EcoR1 Capital

EcoR1 Capital holds 31 positions in its portfolio as reported in the September 2016 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Ironwood Pharmaceuticals (IRWD) 13.7 $45M 2.8M 15.88
Galapagos Nv- (GLPG) 9.9 $32M 501k 64.66
Bristol-myers Squibb 8.3 $27M 500k 53.92
Assembly Biosciences (ASMB) 6.5 $21M 2.9M 7.21
Dermira 5.4 $18M 522k 33.82
Ardelyx (ARDX) 5.2 $17M 1.3M 12.94
Kura Oncology (KURA) 5.0 $16M 2.6M 6.25
Five Prime Therapeutics 4.6 $15M 287k 52.49
Fibrogen (FGEN) 4.4 $14M 686k 20.70
Gilead Sciences Inc option 3.6 $12M 150k 79.12
Allergan Plc call 3.5 $12M 50k 230.32
Agios Pharmaceuticals (AGIO) 3.2 $11M 200k 52.82
Proteostasis Therapeutics In 2.9 $9.4M 602k 15.59
Exact Sciences Corp. cmn 2.9 $9.3M 500k 18.57
Achaogen 2.5 $8.0M 1.7M 4.79
Cytokinetics (CYTK) 2.4 $7.8M 847k 9.18
Kindred Biosciences 2.2 $7.1M 1.4M 4.99
Syndax Pharmaceuticals (SNDX) 1.7 $5.4M 357k 15.16
Beigene (BGNE) 1.6 $5.0M 164k 30.81
Ironwood Pharmaceuticals Inc cl a 1.4 $4.5M 282k 15.88
Ascendis Pharma A S (ASND) 1.4 $4.4M 219k 20.10
Spark Therapeutics 1.3 $4.1M 69k 60.06
Nabriva Therapeutics 1.2 $3.9M 549k 7.05
Adverum Biotechnologies (ADVM) 1.2 $3.9M 946k 4.11
Intellia Therapeutics (NTLA) 1.1 $3.4M 201k 17.02
Chimerix (CMRX) 1.0 $3.3M 598k 5.54
Oncomed Pharmaceuticals 0.9 $3.0M 266k 11.43
Fate Therapeutics (FATE) 0.6 $1.8M 591k 3.12
Chemocentryx 0.3 $1.1M 178k 6.04
Syros Pharmaceuticals 0.3 $882k 64k 13.87
Cascadian Therapeutics Inc call 0.1 $170k 104k 1.64